Measuring the effect of newborn screening on survival after haematopoietic cell transplantation for severe combined immunodeficiency: a 36-year longitudinal study from the Primary Immune Deficiency Treatment ConsortiumMonica S. Thakar, Michael D. Keller, Brent R. Logan et al.|The Lancet|2023Cited by 123
Multicomponent perinatal breastfeeding support in women with BMI >25: The Latch On multi‐centre randomised trialSharleen O’Reilly, Fionnuala M. McAuliffe, Lorraine O’Hagan et al.|BJOG An International Journal of Obstetrics & Gynaecology|2024Cited by 9
Relevance of lymphocyte proliferation to PHA in severe combined immunodeficiency (SCID) and T cell lymphopeniaRoshini S. Abraham, Donald B. Kohn, Amrita Basu et al.|Clinical Immunology|2024Cited by 8
Latch On: A protocol for a multi-centre, randomised controlled trial of perinatal support to improve breastfeeding outcomes in women with a raised BMISharleen O’Reilly, Fionnuala M. McAuliffe, Eileen C. O’Brien et al.|Contemporary Clinical Trials Communications|2021Cited by 7
Transplantation Outcomes for Children with Severe Combined Immune Deficiency (SCID) Have Improved over Time: A 36-Year Summary Report By the Primary Immune Deficiency Treatment Consortium (PIDTC)Monica S. Thakar, Morton J. Cowan, Brent R. Logan et al.|Transplantation and Cellular Therapy|2020Cited by 3